Digene Gel recall: Goa state warns Abbott India on antacid license suspension

The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting August, voluntarily recalled many batches of its Digene Gel syrup produced there after it received customer complaints on taste and odor. Abbott says there is no impact on patient health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AfMkgRy
via IFTTT